SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011390
Filing Date
2017-11-06
Accepted
2017-11-06 08:01:11
Documents
58
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_soligenixinc.htm 10-Q 598938
2 CERTIFICATION f10q0917ex31-1_soligenixinc.htm EX-31.1 10115
3 CERTIFICATION f10q0917ex31-2_soligenixinc.htm EX-31.2 10141
4 CERTIFICATION f10q0917ex32-1_soligenixinc.htm EX-32.1 3639
5 CERTIFICATION f10q0917ex32-2_soligenixinc.htm EX-32.2 3735
  Complete submission text file 0001213900-17-011390.txt   3612714

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20170930.xml EX-101.INS 733847
7 XBRL SCHEMA FILE sngx-20170930.xsd EX-101.SCH 37741
8 XBRL CALCULATION FILE sngx-20170930_cal.xml EX-101.CAL 30573
9 XBRL DEFINITION FILE sngx-20170930_def.xml EX-101.DEF 105036
10 XBRL LABEL FILE sngx-20170930_lab.xml EX-101.LAB 348902
11 XBRL PRESENTATION FILE sngx-20170930_pre.xml EX-101.PRE 214479
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 171178280
SIC: 2834 Pharmaceutical Preparations